OALibJ  Vol.1 No.7 , October 2014
The Addicted Human Brain: An Overview of Imaging Studies and Their Treatment Implications
Abstract: Addiction is characterized by loss of control over substance use, often operationally defined as continued use of substances despite knowledge of adverse consequences. The exact cause of addiction is not known, but it’s hypothesized that both environmental and genetic factors play a crucial role in the predisposition of this disease. When an individual abruptly stops using a drug or an addictive substance, withdrawal symptoms often take place, which include vomiting, nausea, loss of appetite and depression. Not much is known about the neurobiology of addiction and treatment remains a huge challenge. Current research aims at identifying the neurological circuit of addiction as well as the key neurotransmitters and biological markers involved in this disease. In this paper, I will first begin by giving you an overview of the major substances that cause addiction as well as the most common addictive behavior patterns. Second, I will discuss the major findings that have been done using animal models of addiction, and describe in more details the role that brain imaging technology plays in improving our understanding of drug abuse. Finally, a closer look will be taken at the behavioral and pharmacological approaches frequently employed to treat addiction.
Cite this paper: Fakhoury, M. (2014) The Addicted Human Brain: An Overview of Imaging Studies and Their Treatment Implications. Open Access Library Journal, 1, 1-7. doi: 10.4236/oalib.1101033.

[1]   Volkow, N.D., Fowler J.S. and Wang, G.J. (2004) The Addicted Human Brain Viewed in the Light of Imaging Studies: Brain Circuits and Treatment Strategies. Neuropharmacology, 47, 3-13.

[2]   Badiani, A., Belin, D., Epstein, D., Calu, D. and Shaham, Y. (2011) Opiate versus Psychostimulant Addiction: The Differences Do Matter. Nature Reviews Neuroscience, 12, 685-700.

[3]   Howell, L.L. and Murnane, K.S. (2008) Nonhuman Primate Neuroimaging and the Neurobiology of Psychostimulant Addiction. Annals of the New York Academy of Sciences, 1141, 176-194.

[4]   Tapocik, J.D. (2014) MicroRNA-206 in Rat Medial Prefrontal Cortex Regulates BDNF Expression and Alcohol Drinking. The Journal of Neuroscience, 34, 4581-4588.

[5]   Kamangar, F, Shakeri, R., Malekzadeh, R. and Islami, F. (2014) Opium Use: An Emerging Risk Factor for Cancer? The Lancet Oncology, 15, e69-e77.

[6]   Connock, M., et al. (2007) Methadone and Buprenorphine for the Management of Opioid Dependence: A Systematic Review and Economic Evaluation. Health Technology Assessment, 11, 1-171, iii-iv.

[7]   Kiluk, B.D. and Carroll, K.M. (2013) New Developments in Behavioral Treatments for Substance Use Disorders. Current Psychiatry Reports, 15, 420.

[8]   Duncan, J.R. (2012) Current Perspectives on the Neurobiology of Drug Addiction: A Focus on Genetics and Factors Regulating Gene Expression. ISRN Neurology, 2012, Article ID: 972607.

[9]   Habibi, Z., Tourani, S., Sadeghi, H. and Abolghasemi, A. (2013) Effectiveness of Stress Management Skill Training on the Depression, Anxiety and Stress Levels in Drug Addicts after Drug Withdrawal. International Journal of High Risk Behaviors and Addiction, 2, 82-86.

[10]   Koob, G.F. and Simon, E.J. (2009) The Neurobiology of Addiction: Where We Have Been and Where We Are Going. Journal of Drug Issues, 39, 115-132.

[11]   Potenza, M.N. (2006) Should Addictive Disorders Include Non-Substance-Related Conditions? Addiction, 101, 142-151.

[12]   Parashar, A. and Varma, A. (2007) Behavior and Substance Addictions: Is the World Ready for a New Category in the DSM-V? CNS Spectrums, 12, 257-259.

[13]   Grant, J.E. and Chamberlain, S.R. (2014) Impulsive Action and Impulsive Choice across Substance and Behavioral Addictions: Cause or Consequence? Addictive Behaviors, 39, 1632-1639.

[14]   Chou, K.L. and Afifi, T.O. (2011) Disordered (Pathologic or Problem) Gambling and Axis I Psychiatric Disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. American Journal of Epidemiology, 173, 1289-1297.

[15]   McElroy, S.L., Keck, P.E., Pope, H.G., Smith, J.M. and Strakowski, S.M. (1994) Compulsive Buying: A Report of 20 Cases. Journal of Clinical Psychiatry, 55, 242-248.

[16]   Black, D.W. (2007) A Review of Compulsive Buying Disorder. World Psychiatry, 6, 14-18.

[17]   Alavi, S.S., Ferdosi, M., Jannatifard, F., Eslami, M., Alaghemandan, H. and Setare, M. (2012) Behavioral Addiction versus Substance Addiction: Correspondence of Psychiatric and Psychological Views. International Journal of Preventive Medicine, 3, 290-294.

[18]   Lynch, W.J., Nicholson, K.L., Dance, M.E., Morgan, R.W. and Foley, P.L. (2010) Animal Models of Substance Abuse and Addiction: Implications for Science, Animal Welfare and Society. Comparative Medicine, 60, 177-188.

[19]   Koob, G.F. and Le Moal, M. (1997) Drug Abuse: Hedonic Homeostatic Dysregulation. Science, 278, 52-58.

[20]   Cousins, V., Rose, J.E. and Levin, E.D. (2014) IV Nicotine Self-Administration in Rats Using a Consummatory Operant Licking Response: Sensitivity to Serotonergic, Glutaminergic and Histaminergic Drugs. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 54, 200-205.

[21]   Caine, S.B. and Koob, G.F. (1993) Modulation of Cocaine Self-Administration in the Rat through D-3 Dopamine Receptors. Science, 260, 1814-1816.

[22]   Emmett-Oglesby, M.W., Mathis, D.A., Moon, R.T.Y. and Lal, H. (1990) Animal Models of Drug Withdrawal Symptoms. Psychopharmacology, 101, 292-309.

[23]   Watanabe, S. (1985) Drug Discrimination: Methodology and Current Problems. Yakubutsu Seishin Kodo, 5, 289-302.

[24]   Becker, H.C. (2000) Animal Models of Alcohol Withdrawal. Alcohol Research & Health, 24,105-113.

[25]   McBride, W.J. and Li, T.K. (1998) Animal Models of Alcoholism: Neurobiology of High Alcohol-Drinking Behavior in Rodents. Critical Reviews in Neurobiology, 12, 339-369.

[26]   Murphy, J.M., Gatto, G.J., Waller, M.B., McBride, W.J., Lumeng, L. and Li, T.K. (1986) Effects of Scheduled Access on Ethanol Intake by the Alcohol-Preferring (P) Line of Rats. Alcohol, 3, 331-336.

[27]   Fowler, J.S., Volkow, N.D., Kassed, C.A. and Chang, L. (2007) Imaging the Addicted Human Brain. Science & Practice Perspectives, 3, 4-16.

[28]   Volkow, N.D., Fowler, J.S. and Wang, G.J. (2003) The Addicted Human Brain: Insights from Imaging Studies. Journal of Clinical Investigation, 111, 1444-1451.

[29]   Catafau, A.M., Searle, G.E., Bullich, S., et al. (2010) Imaging Cortical Dopamine D1 Receptors Using [11C]NNC112 and Ketanserin Blockade of the 5-HT2A Receptors. Journal of Cerebral Blood Flow & Metabolism, 30, 985-993.

[30]   Le Foll, B., Collo, G., Rabiner, E.A., et al. (2014) Chapter 11—Dopamine D3 Receptor Ligands for Drug Addiction Treatment: Update on Recent Findings. Progress in Brain Research, 211, 255-275.

[31]   Pfefferbaum, A., Sullivan, E.V., Rosenbloom, M.J., Mathalon, D.H. and Lim, K.O. (1998) A Controlled Study of Cortical Gray Matter and Ventricular Changes in Alcoholic Men over a 5-Year Interval. Archives of General Psychiatry, 55, 905-912.

[32]   Parvaz, M.A., Alia-Klein, N., Woicik, P.A., Volkow, N.D. and Goldstein, R.Z. (2011) Neuroimaging for Drug Addiction and Related Behaviors. Reviews in the Neurosciences, 22, 609-624.

[33]   Thompson, P.M., Hayashi, K.M., Simon, S.L., et al. (2004) Structural Abnormalities in the Brains of Human Subjects Who Use Methamphetamine. The Journal of Neuroscience, 24, 6028-6036.

[34]   Potenza, M.N., Sofuoglu, M., Carroll, K.M. and Rounsaville, B.J. (2011) Neuroscience of Behavioral and Pharmacological Treatments for Addictions. Neuron, 69, 695-712.

[35]   Yip, S.W. and Potenza, M.N. (2014) Treatment of Gambling Disorders. Current Treatment Options in Psychiatry, 1, 189-203.

[36]   Dutra, L., Stathopoulou, G., Basden, S.L., Leyro, T.M., Powers, M.B. and Otto, M.W. (2008) A Meta-Analytic Review of Psychosocial Interventions for Substance Use Disorders. American Journal of Psychiatry, 165, 179-187.

[37]   Magill, M. and Ray, L.A. (2009) Cognitive-Behavioral Treatment with Adult Alcohol and Illicit Drug Users: A Meta-Analysis of Randomized Controlled Trials. Journal of Studies on Alcohol and Drugs, 70, 516-527.

[38]   Minozzi, S., Amato, L., Bellisario, C. and Davoli, M. (2014) Maintenance Treatments for Opiate-Dependent Adolescents. Cochrane Database of Systematic Reviews, 24, 6.

[39]   Mattick, R.P., Breen, C., Kimber, J. and Davoli, M. (2003) Methadone Maintenance Therapy versus No Opioid Replacement Therapy for Opioid Dependence. Cochrane Database of Systematic Reviews, 2.

[40]   Maxwell, S., Bigg, D., Stanczykiewicz, K. and Carlberg-Racich, S. (2006) Prescribing Naloxone to Actively Injecting Heroin Users: A Program to Reduce Heroin Overdose Deaths. Journal of Addictive Diseases, 25, 89-96.

[41]   Gorelick, D.A. and Wilkins, J.N. (2006) Bromocriptine Treatment for Cocaine Addiction: Association with Plasma Prolactin Levels. Drug and Alcohol Dependence, 81, 189-195.

[42]   O’Brien, E.S., Legastelois, R., Houchi, H., et al. (2011) Fluoxetine, Desipramine and the Dual Antidepressant Milnacipran Reduce Alcohol Self-Administration and/or Relapse in Dependent Rats. Neuropsychopharmacology, 36, 1518-1530.